How Good is Ultra-Long GnRH-a Treatment Before IVF for Women With Endometriosis?

How Good is Ultra-Long GnRH-a Treatment Before IVF for Women With Endometriosis? By Özge Özkaya

Pretreatment with ultra-long gonadotropin-releasing hormone agonist (GnRH-a), i.e. for at least three months before in vitro fertilization (IVF), has an adverse effect on patient pregnancy outcomes with endometriosis, according to a meta-analysis of the literature published in the Journal of…

Key Points Lay Summary

Women With More Severe Endometriosis Have Fewer Eggs

Women With More Severe Endometriosis Have Fewer Eggs By Özge Özkaya

Severe endometriosis negatively affects ovarian response and the quality of oocytes and embryos, according to a new study published in JBRA Assisted Reproduction. However, the rate of fertilization does not seem to be affected by endometriosis stage.  These findings could…

Key Points Lay Summary

Fertilization rate and pregnancy outcome in IVF cycles of endometriosis.

Fertilization rate and pregnancy outcome in IVF cycles of endometriosis. By Selma Oransay

Endometriosis affects the pelvic cavity, uterus, ovaries and causes impaired fertility as a result. The chronic inflammatory nature of this disease negatively impacts the oocyte quality, maturation, and fertilization. Obviously, fewer oocytes can be harvested in the IVF cycles of…

Key Points Lay Summary